iPS-cell technology and the problem of genetic instability—can it ever be safe for clinical use? by Attwood, SW, Edel, MJ

Phylogenetic and phylodynamic approaches to understanding and combating the early SARS-CoV-2 pandemic by Attwood, SW, Hill, SC, Aanensen, DM, Connor, TR, Pybus, OG

An integrated national scale SARS-CoV-2 genomic surveillance network by COVID-19 Genomics UK (COG-UK) consortiumcontact@cogconsortium.uk, Attwood, SW

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway by Willett, BJ, Grove, J, MacLean, OA, Klenerman, P, Dunachie, S, Barnes, E, Brown, A, Adele, S, Kronsteiner, B, Murray, SM, Abraham, P, Deeks, A, Ansari, MA, Fraser, C, Bonsall, D, Fryer, H, Lythgoe, K, Thomson, L, Golubchik, T, Underwood, AP, Taylor, BEW, Yeats, CA, Aanensen, DM, Abudahab, K, Menegazzo, M, Zarebski, AE, Gutierrez, B, Raghwani, J, du Plessis, L, Kraemer, MUG, Pybus, OG, Francois, S, Attwood, SW, Vasylyeva, TI, Trebes, A, Green, A, Buck, D, MacIntyre-Cockett, G, Todd, JA